Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility/First in Human Study of Visible Spectrum, Low Level, Microbicidal Light-based Intravaginal Therapy for Treatment of Yeast and Bacterial Vaginitis

NCT06933420 is registered in ClinicalTrials.gov with Cern Corporation as lead sponsor.

NCT NCT06933420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06933420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility/First in Human Study of Visible Spectrum, Low Level, Microbicidal Light-based Intravaginal Therapy for Treatment of Yeast and Bacterial Vaginitis
Lead sponsor
Cern Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
November 6, 2024
Completion date
May 31, 2025
Enrollment
9 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis, fungal vaginal infections